Audit 8807

FY End
2023-06-30
Total Expended
$42.78M
Findings
0
Programs
32
Year: 2023 Accepted: 2023-12-28
Auditor: Windes INC

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
10.557 Special Supplemental Nutrition Program for Women, Infants, and Children $15.39M - 0
93.865 Child Health and Human Development Extramural Research $5.31M Yes 0
93.855 Allergy, Immunology and Transplantation Research $4.24M Yes 0
93.837 Cardiovascular Diseases Research $1.45M Yes 0
12.420 Military Medical Research and Development $1.41M Yes 0
93.838 Lung Diseases Research $1.31M Yes 0
93.226 Research on Healthcare Costs, Quality and Outcomes $805,016 Yes 0
93.121 Oral Diseases and Disorders Research $365,290 Yes 0
93.127 Emergency Medical Services for Children $236,607 Yes 0
93.242 Mental Health Research Grants $216,930 Yes 0
93.866 Aging Research $209,147 Yes 0
93.889 National Bioterrorism Hospital Preparedness Program $148,725 Yes 0
93.213 Research and Training in Complementary and Integrative Health $143,497 Yes 0
93.350 National Center for Advancing Translational Sciences $131,624 Yes 0
93.000 Nih Small Business Innovation Research $111,863 Yes 0
93.107 Area Health Education Centers Point of Service Maintenance and Enhancement Awards $105,915 Yes 0
93.110 Maternal and Child Health Federal Consolidated Programs $105,703 Yes 0
93.185 Immunization Research, Demonstration, Public Information and Education_training and Clinical Skills Improvement Projects $93,176 Yes 0
93.U00 Centers for Disease Control and Prevention $80,825 Yes 0
93.307 Minority Health and Health Disparities Research $68,954 Yes 0
12.U00 US Department of Defense $49,498 Yes 0
84.184S School Emergency Response to Violence $40,466 Yes 0
47.040 Computer & Information Science & Engineering $38,567 Yes 0
93.279 Drug Abuse and Addiction Research Programs $32,893 Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $26,632 Yes 0
93.859 Biomedical Research and Research Training $26,393 Yes 0
93.310 Trans-Nih Research Support $24,059 Yes 0
93.172 Human Genome Research $23,366 Yes 0
93.846 Arthritis, Musculoskeletal and Skin Diseases Research $20,847 Yes 0
93.233 National Center on Sleep Disorders Research $19,443 Yes 0
93.393 Cancer Cause and Prevention Research $10,935 Yes 0
93.273 Alcohol Research Programs $7,644 Yes 0

Contacts

Name Title Type
LTJVF4QSFCP9 Michael Jones Auditee
3102223664 Kelly Buck Auditor
No contacts on file

Notes to SEFA

Title: NOTE 1 – Basis of Presentation Accounting Policies: Expenditures on the schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts reflected in the schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: N Rate Explanation: The Institute has elected not to use the 10% de minimis indirect cost rate as allowed under the Uniform Guidance. The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (the Institute), formerly known as Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, is an independent biomedical research institute. The accompanying schedule of expenditures of federal awards is prepared on the accrual basis of accounting. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in this schedule may differ from amounts presented in, or used in the preparation of, the basic financial statements.
Title: NOTE 2 – Summary of Significant Accounting Policies Accounting Policies: Expenditures on the schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts reflected in the schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: N Rate Explanation: The Institute has elected not to use the 10% de minimis indirect cost rate as allowed under the Uniform Guidance. Expenditures on the schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts reflected in the schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years.
Title: NOTE 3 – Indirect Cost Rate Accounting Policies: Expenditures on the schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts reflected in the schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: N Rate Explanation: The Institute has elected not to use the 10% de minimis indirect cost rate as allowed under the Uniform Guidance. The Institute has elected not to use the 10% de minimis indirect cost rate as allowed under the Uniform Guidance.